Skip to main content


All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

A través dels grups de recerca de Malalties Infeccioses i de Microbiologia, participem en assaigs clínics per trobar nous esquemes terapèutics per a les persones amb tuberculosi.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Júlia Baguña, Andrea Guala i Roberto Orsenigo han rebut una dels 105 ajuts concedits en el marc del programa INPhINIT i les 40 del programa Junior Leader.

The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine

A study involving the Vall d'Hebron Research Institute (VHIR) shows that moderate and high caffeine consumption is associated with a 65% reduction of the risk of suffering diabetic retinopathy in people with type 2 diabetes.

The international study, in which Vall d'Hebron participated, monitored patients who were hospitalized for COVID-19 for 12 months and compared their gastrointestinal symptoms with another group of patients diagnosed with other medical pathologies.

The work of the Microbiology group of VHIR will optimize a diagnostic algorithm for the screening of hepatitis D virus infection in Barcelona.

El 20% dels pacients en els quals s’havia trobat alguna predisposició genètica van ser diagnosticats amb algun tipus de tumor i van poder iniciar el tractament de manera precoç.

Amb motiu del Dia Mundial de l’Endometriosi, destaquem la recerca que desenvolupen els i les nostres professionals en aquest camp.

The funded project is investigating the biological mechanisms of metastasis and hopes to improve the survival of patients with this type of tumor with the development of new therapies.

The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men

With this agreement, the Hospital and the Vall d’Hebron Research Institute (VHIR) has officially become a part of the Barcelona Health Hub ecosystem, providing them with an opportunity to connect with leading digital health players across the globe.

72% of the Vall d’Hebron Barcelona Hospital Campus employees are women: We have celebrated 8-M with an act where our professionals have been the headliners.

The research, led by nurse Zahira Pérez, focuses on the description of possible factors that alter sexual function in people diagnosed with inflammatory bowel disease

The variants of the virus at the beginning of the pandemic presented defective genomes in the spike gene, that is, some viral particles lacked part of the key genomic material to infect new cells.

The call will fund a project on the impact of the Low Emission Zone on the incidence of arrhythmias and another to stop liver disease related to alcohol consumption.

The two centres call on people with a diagnosis of cancer over 65-years-old and living in Barcelona to participate in the trial.

Els actes amb motiu del Dia de les Malalties Minoritàries fan possible que pacients amb malalties diferents es trobin i s’ajudin

The Clinical and Translational Bioinformatics group is launching the project to use cutting-edge artificial intelligence in the identification of pathogenic variants.

Understanding the genetics of ADHD and the association with other pathologies will help to prevent and diagnose patients early and facilitate research into new targeted therapies.

Els guardons tenen la finalitat d’honorar les persones i entitats que s’hagin destacat de manera significativa pels serveis prestats amb vista al progrés i la millora de la sanitat. 

La recerca de la doctora Eva Colás, investigadora del VHIR, busca identificar biomarcadors en el fluid cervical de les pacients per a agilitzar i facilitar la detecció de la patologia.


The goal is to test a low-cost, easy-to-use and non-invasive monitor, which will serve to control intracranial pressure (PICO) values, which will help to control and treat different acute brain pathologies.

The researcher of the Renal Pathophysiology group at VHIR investigates the role of ClC-5 protein in the development of this rare kidney disease.